Evidence map›Paper›PMID 33882634›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2021

Pre-Conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation

Fatma Visal Okur, Murat Karapapak, Khaled Warasnhe, Umut Ece Aslan, Barış Kuşkonmaz, Duygu Çetinkaya

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fatma Visal OkurHacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Pediatric BMT Unit, Ankara, TurkeyORCID 0000-0002-1679-6205
Murat KarapapakHacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Pediatric BMT Unit, Ankara, TurkeyORCID 0000-0001-9604-6887
Khaled WarasnheHacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Pediatric BMT Unit, Ankara, TurkeyORCID 0000-0002-0781-5814
Umut Ece AslanHacettepe University, Institute of Public Health, Department of Health Research, Ankara, TurkeyORCID 0000-0002-0884-8079
Barış KuşkonmazHacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Pediatric BMT Unit, Ankara, TurkeyORCID 0000-0002-1207-4205
Duygu ÇetinkayaHacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Pediatric BMT Unit, Ankara, TurkeyORCID 0000-0003-3593-6493
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Uric acid (UA), a known danger signal released from injured cells, is a valuable sign of inflammation. We aimed to evaluate the association of serum UA levels before the start of conditioning regimens with the risk of hepatic sinusoidal obstruction syndrome (SOS) development after hematopoietic stem cell transplantation (HSCT). Materials and Methods: Two hundred and twenty-two children who underwent allogeneic HSCT at the Pediatric BMT Unit of Hacettepe University between 2000 and 2014 were included in this retrospective study. Serum UA levels were measured before conditioning as an indicator of the pre-transplant inflammatory status of the patients. Patients with and without a diagnosis of SOS were compared regarding primary diagnosis, previously described risk factors for SOS, and pre-conditioning serum UA. Results: SOS was diagnosed in 42 patients who had higher pre-conditioning serum UA levels compared to those who did not. Pre-transplant serum creatinine, gamma-glutamyl transferase, bilirubin, ferritin, and C-reactive protein levels did not differ significantly among patients with and without SOS; however, serum albumin was lower in the patients who developed SOS. Receiver operating characteristic analysis revealed that a pre-conditioning UA level higher than 3.32 mg/dL was predictive of SOS. When applied to a multivariate model, only pre-conditioning UA and albumin levels remained significant risk factors for SOS (UA: odds ratio [OR], 2.54; 95% confidence interval [CI], 1.26-5.12, p=0.009; albumin: OR, 0.45, 95% CI, 0.22-0.95, p=0.037). Conclusion: Our results suggest that pre-conditioning serum UA is an independent risk factor for SOS, and it might be used as an early predictor of hepatic SOS together with previously described clinical and laboratory parameters.

Indexed as

Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseUric AcidChildHumansRetrospective StudiesRisk FactorsUric Acidematopoietic stem celltransplantationInflammationSinusoidal obstruction syndromeUric acid

Identifiers

PMID33882634
PMCPMC8656132
OpenAlexW3154149004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.